Botulinum toxin A brands are not the same medications. A comment on Hary et al
- PMID: 35511458
- DOI: 10.1002/ejp.1969
Botulinum toxin A brands are not the same medications. A comment on Hary et al
Comment on
-
Efficacy and safety of botulinum A toxin for the treatment of chronic peripheral neuropathic pain: A systematic review of randomized controlled trials and meta-analysis.Eur J Pain. 2022 May;26(5):980-990. doi: 10.1002/ejp.1941. Epub 2022 Mar 23. Eur J Pain. 2022. PMID: 35293078
References
REFERENCES
-
- Hary, V., Schitter, S., Martinez, V. (2022). Efficacy and safety of botulinum a toxin for the treatment of chronic peripheral neuropathic pain: A systematic review of randomized controlled trials and meta-analysis. Eur J pain, 26(5), 980-990. doi: https://doi.org/10.1002/ejp.1941.
-
- Slawek, J., & Jost, W. H. (2021). Botulinum neurotoxin in neurological practice - a leading topic in neurology. Neurol Neurochir Pol, 55(2), 120-124. https://doi.org/10.5603/PJNNS.a2021.0034
-
- Slawek, J., Bogucki, A., Bonikowski, M., Car, H., Dec-Ćwiek, M., Drużdż, A., Koziorowski, D., Sarzyńska-Długosz, I., & Rudzińska, M. (2021). Botulinum toxin type-a preparations are not the same medications - Clinical studies (part 2). Neurol Neurochir Pol, 55(2), 141-157. https://doi.org/10.5603/PJNNS.a2021.0028
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
